JP Morgan Chase
HITK

JP Morgan Chase’s HI-TECH PHARMACAL INC HITK Stock Holding History

JP Morgan Chase’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-354,818
Closed -$15.4M – 3755
2014
Q1 		$15.4M Buy
354,818
+11,202
+3% +$486K ﹤0.01% 1484
2013
Q4 		$14.9M Buy
343,616
+48,537
+16% +$2.1M ﹤0.01% 1518
2013
Q3 		$12.7M Buy
295,079
+265,964
+913% +$10.2M ﹤0.01% 1601
2013
Q2 		$966K Buy
+29,115
New +$969K ﹤0.01% 3281

JP Morgan Chase's HITK Position: Q2 2014 in Review

JP Morgan Chase sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 354,818 shares — an estimated $15.4M sold.

JP Morgan Chase first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $15.4M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • JP Morgan Chase reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • JP Morgan Chase sold 354,818 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $15.4M.
  • JP Morgan Chase first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • JP Morgan Chase's HI-TECH PHARMACAL INC position peaked at $15.4M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on JP Morgan Chase's 13F filing for Q2 2014, filed 14 Aug 2014.